PUBLIC COMPANY
save$COYACoya Therapeutics, Inc.
$COYAHouston, TX, USupdated 2mo ago
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 2
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
Insider activity
source: SEC Form 4routine RSU / option mechanics (1)
- Apr 9, 26grantPavao Mark H · director10,000 sh
🐶 Hiring Signal
News
- Axoltis misses the mark in phase 2 ALS study, but will persevere with the synthetic peptideAxoltis Pharma's phase 2 trial for amyotrophic lateral sclerosis may have missed its primary endpoint, but the French biotech has pointed to secondary endpoints to justify persevering with the synt…fiercebiotech · 18d ago
Data sources
last refreshed 37m ago
Found something off?
comments(0)
5-min edit window · permanent after that